期刊
JOURNAL OF NEUROSCIENCE RESEARCH
卷 101, 期 12, 页码 1900-1913出版社
WILEY
DOI: 10.1002/jnr.25249
关键词
blood-cerebrospinal fluid barrier; brain metastasis; breast cancer; chemotherapy; CSF; tau
This study investigates the impact of chemotherapy on breast-to-brain metastasis and the promotion of tumor-driven neurofibrillary tangles. The results show that chemotherapy increases brain-barrier permeability and facilitates tumor infiltration. Chemotherapy also contributes to the formation of neurofibrillary tangles that destabilize the brain barrier.
Control of breast-to-brain metastasis remains an urgent unmet clinical need. While chemotherapies are essential in reducing systemic tumor burden, they have been shown to promote non-brain metastatic invasiveness and drug-driven neurocognitive deficits through the formation of neurofibrillary tangles (NFT), independently. Now, in this study, we investigated the effect of chemotherapy on brain metastatic progression and promoting tumor-mediated NFT. Results show chemotherapies increase brain-barrier permeability and facilitate enhanced tumor infiltration, particularly through the blood-cerebrospinal fluid barrier (BCSFB). This is attributed to increased expression of matrix metalloproteinase 9 (MMP9) which, in turn, mediates loss of Claudin-6 within the choroid plexus cells of the BCSFB. Importantly, increased MMP9 activity in the choroid epithelium following chemotherapy results in cleavage and release of Tau from breast cancer cells. This cleaved Tau forms tumor-derived NFT that further destabilize the BCSFB. Our results underline for the first time the importance of the BCSFB as a vulnerable point of entry for brain-seeking tumor cells post-chemotherapy and indicate that tumor cells themselves contribute to Alzheimer's-like tauopathy. This study explores the relationship between cancer and neuroscience, focusing on how the nervous system impacts breast-to-brain metastasis (BBM). Chemotherapy's impact on tumor spread and cognitive function is explored, revealing that it increases brain-barrier permeability, aiding tumor infiltration through Matrix metalloproteinase 9 (MMP9) expression and Claudin-6 loss (A). Likewise, chemotherapy-induced MMP9 activity also contributes to tumor-derived neurofibrillary tangles leading to potential neurodegeneration (B). The study elucidates the vulnerability of the brain barrier and proposes a link between tumor cells and Alzheimer's-like tauopathy.image
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据